Latest debt-to-equity ratio
INmune Bio Debt-to-equity ratio
Direct answer
INmune Bio's debt-to-equity ratio is 6.9%.
The verified market snapshot reports 6.9%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 6.9%